The clinical significance of the lymphocyte subsets in systemic lupus erythematosus patients

Hu Zonghai,Wu Lijuan,Xie Jing,Liu Yugang,Peng Yan,Chen Li,Li Qunying,Li Jihong
DOI: https://doi.org/10.3969/j.issn.1673-4130.2011.20.003
2011-01-01
Abstract:Objective To investigate the clinical significance of the lymphocyte cell subsets in treatment the systemic lupus erythematosus(SLE) of the various stages.Methods The CD3+,CD3+CD4+,CD3+CD8+,CD3-CD19+(B cells) and CD3-CD16+CD56+(NK cells) cells were detected of the 56 cases inⅠ,Ⅱand Ⅲ active stage SLE and 20 normal control with the flow cytometry.Results There was no significant difference(P>0.05) between the active SLE patients in active stage Ⅰ and the control group.There was significant difference(P<0.05) between the Active SLE patients Ⅱ,Ⅲ active and normal control group of the CD3+CD4+/CD3+CD8+ ratio and the B cells and the NK.There was no significant difference(P>0.05) between the active SLE patients in active stage Ⅱ and the control group of the CD3+CD8+ cells(P>0.05).Conclusion There was reference value of the lymphocyte subsets to therapy the SLE.
What problem does this paper attempt to address?